Die Anwendung von recombinant tissue plasminogen activator (rt-PA) in der Augenheilkunde
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Tübingen, Universität Tübingen, Dissertation, 2014
- Keyword
-
Aktivator
Fibrin
Augenheilkunde
Plasminogen human-Aktivator
Blutung
Fibrinolyse
Medizin
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (who)
-
Universitätsbibliothek Tübingen
- (when)
-
2015
- Creator
-
Arslan-Öztürk, Öznur
- Contributor
-
Bartz-Schmidt, K. U.
- URN
-
urn:nbn:de:bsz:21-dspace-634043
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Arslan-Öztürk, Öznur
- Bartz-Schmidt, K. U.
- Universitätsbibliothek Tübingen
Time of origin
- 2015
Other Objects (12)
A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy
Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
Experimentelle Untersuchung zur Ko-Applikation von recombinant tissue Plasminogen Activator (rtPA) und Bevacizumab bei neovaskulärer AMD mit submakulärer Blutung
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Might life-threatening acute pulmonary edema occur after using recombinant tissue plasminogen activator? A case report
A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy
Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
Experimentelle Untersuchung zur Ko-Applikation von recombinant tissue Plasminogen Activator (rtPA) und Bevacizumab bei neovaskulärer AMD mit submakulärer Blutung
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Might life-threatening acute pulmonary edema occur after using recombinant tissue plasminogen activator? A case report
A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy
Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
Experimentelle Untersuchung zur Ko-Applikation von recombinant tissue Plasminogen Activator (rtPA) und Bevacizumab bei neovaskulärer AMD mit submakulärer Blutung
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy